MannKind Corporation
MannKind Corporation (United States) holds 2 active US FDA Type II Drug Master Files and 1 inactive. 3 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “MannKind Corporation: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/mannkind-corporation
Overview
MannKind Corporation is a biopharmaceutical company specializing in the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes. Their flagship product, Afrezza, is an inhalable insulin used to control high blood sugar in adults with diabetes. The company is dedicated to advancing a pipeline of innovative treatments to manage chronic and debilitating conditions.
Therapeutic areas
API / Drug Master Files
MannKind Corporation holds 2 active (3 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- TREPROSTINIL INHALATION POWDERActive2018-10-17
- AFREZZA® INHALATION POWDER AND AFREZZA® INHALERActive2014-10-15
- INSULIN, HUMAN (RDNA HUMAN INSULIN) HMR 4006Inactive2003-03-26
FDA compliance signals
3 FDA enforcement records linked to this company.
- warning_letter2018-10-05
FDA Warning Letter (drug product)
- 4832013-05-17
Extent of discrepancy, failure investigations
- 4832013-05-17
Actual vs. theoretical yields not determined
Is this MannKind Corporation?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.